Skip to main content

Find Clinical Trials

Home
Conditions
Unresectable Adrenal Cortex Carcinoma

Clinical trial condition

Unresectable Adrenal Cortex Carcinoma

Explore clinical trials studying Unresectable Adrenal Cortex Carcinoma. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Unresectable Adrenal Cortex Carcinoma trial results

Recruiting

Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer

NCT06006013

Conditions: Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +15 more
Locations: Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Completed

Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma

NCT03370718

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +9 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details